A screening tool for cervical cancer is sparking a medical debate. The test from Roche uses DNA to detect HPV. This type of technology is already available. Now Roche wants the FDA to approve it as a first-choice option for screening, bypassing the pap smear test.
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.